Opt-out testing for human immunodeficiency virus in the United States: Progress and challenges

JAMA

Volumn 300, Issue 8, 2008, Pages 945-951

  Bartlett, John G ^a   Branson, Bernard M ^b   Fenton, Kevin ^b   Hauschild, Benjamin C ^c   Miller, Veronica ^c   Mayer, Kenneth H ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; COUNSELING; DISEASE CONTROL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH SURVEY; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFORMED CONSENT; LAW; MASS SCREENING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCREENING TEST; UNITED STATES;

EID: 50449083378     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.8.945     Document Type: Article

References (47)

1. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWRMorb Mortal Wkly Rep. 2006;55(1)(RR-14):1-14.
2. Swamy M. UN agencies issue new guidelines for HIV testing. HIV AIDS Policy Law Rev. 2007;12(2-3):39-40.
3. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138(8):620-626.
4. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447-1450.
5. Branson BM. State of the art for diagnosis of HIV infection. Clin Infect Dis. 2007;45(suppl 4):S221-S225.
6. Burke RC, Sepkowitz KA, Bernstein KT, et al. Why don't physicians test for HIV? a review of the US literature. AIDS. 2007;21(12):1617-1624.
7. Walensky RP, Weinstein MC, Kimmel AD, Seage GR III, Losina E, Sax PE. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005;118(3):292-300.
8. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydazk CE. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570-585.
9. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl J Med. 2005;352(6):586-595.
10. Centers for Disease Control and Prevention. Late versus early testing of HIV-16 sites, United States 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52(25):581-586.
11. Palella FJ Jr, Delaney KM, Moorman AC, et al; HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853-860.
12. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194(1):11-19.
13. Moore R, Keruly J, Bartlett JG. Person-years lost by late presentation for HIV care in Maryland. Presented at: 15th Conference on Retroviruses and Opportunistic Infections; February 3-6, 2008; Boston, MA. Abstract 805.
14. Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral naïve persons from 1990 to 2006. Clin Infect Dis. 2007;45(10):1369-1374.
15. Centers for Disease Control and Prevention. Missed opportunities for earlier diagnosis of HIV infection - South Carolina, 1997-2005. MMWR Morb Mortal Wkly Rep. 2006;55(47):1269-1272.
16. Sullivan PS, Lansky A, Drake A; HITS-2000 Investigators. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. J Acquir Immune Defic Syndr. 2004;35(5):511-518.
17. Valdiserri RO, Moore M, Gerber AR, Campbell CH Jr, Dillion BA, West GR. A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep. 1993;108(1):12-18.
18. Hanssens C. Legal and ethical implications of optout testing. Clin Infect Dis. 2007;45(suppl 4):S232-S239.
19. Gostin LO. HIV screening in health care settings: public health and civil liberties in conflict? JAMA. 2006;296(16):2023-2025.
20. Lifson AR, Rybicki SL. Routine opt-out HIV testing. Lancet. 2007;369(9561):539-540.
21. Valdiserri RO. Late HIV diagnosis: bad medicine and worse public health. PLoS Med. 2007;4(6):e200.
22. Holtgrave DR. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing. PLoS Med. 2007;4(6):e194.
23. Gruskin S, Ahmed S, Ferguson L. Provider-initiated HIV testing and counseling in health facilities - what does this mean for the health and human rights of pregnant women? Dev World Bioeth. 2008;8(1):23-32.
24. Wynia MK. Routine screening: informed consent, stigma and the waning of HIV exceptionalism. Am J Bioeth. 2006;6(4):5-8.
25. Bayer R, Fairchild AL. Changing the paradigm for HIV testing - the end of exceptionalism. N Engl J Med. 2006;355(7):647-649.
26. National HIV/AIDS Clinicians' Consultation Center. State HIV testing laws, 2008. http://www.ucsf.edu/hivcntrr/statelaws/Index.html. Accessed August 1, 2008.
27. Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G; Project RESPECT Study Group. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA. 1998;280(13):1161-1167.
28. Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health. 1999;89(9):1397-1405.
29. Ostermann J, Kumar V, Pence BW, Whetten K. Trends in HIV testing and differences between planned and actual testing in the United States, 2000-2005. Arch Intern Med. 2007;167(19):2128-2135.
30. Department of Health and Human Services. HIV/AIDS Surveillance Report 2006: cases of HIV infection and AIDS in the United States and dependent areas. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2006report/pdf/ 2006SurveillanceReport.pdf. Accessed July 28, 2008.
31. Fenton KA. Changing epidemiology of HIV/AIDS in the United States: implications for enhancing and promoting HIV testing strategies. Clin Infect Dis. 2007;45(suppl 4):S213.
32. Centers for Disease Control and Prevention. Racial/ethnic disparities in diagnoses of HIV/AIDS-3 states, 2001-2005. MMWR Morb Mortal Wkly Rep. 2007;56(9):189-193.
33. Kates J, Levi J. Insurance coverage and access to HIV testing and treatment: considerations for individuals at risk for infection and for those with undiagnosed infection. Clin Infect Dis. 2007;45(suppl 4):S255-S260.
34. Rothman RE. Current Centers for Disease Control and Prevention guidelines for HIV counseling, testing, and referral: critical role of and a call to action for emergency physicians. Ann Emerg Med. 2004;44(1):31-42.
35. Kelen GD, Shahan JB, Quinn TC. Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med. 1999;33(2):147-155.
36. Mollen C, Lavelle J, Hawkins L, Ambrose C, Ruby B. Description of a novel pediatric emergency department-based HIV screening program for adolescents. AIDS Patient Care STDS. 2008;22(6):505-512.
37. Calderon Y, Haughey M, Bijur PE, et al. An educational HIV pretest counseling video program for offhours testing in the emergency department [published ahead of print March 13, 2006]. Ann Emerg Med. 2006;48(1):21-27.
38. Haukoos JS, Hopkins E, Eliopoulos VT, et al. Development and implementation of a model to improve identification of patients infected with HIV using diagnostic rapid testing in the emergency department. Acad Emerg Med. 2007;14(12):1149-1157.
39. Centers for Disease Control and Prevention. Rapid HIV testing in emergency departments - three US sites, January 2005-March 2006. MMWR Morb Mortal Wkly Rep. 2007;56(24):597-601.
40. Ehrenkranz PD, Ahn CJ, Metlay JP, Camargo CA Jr, Holmes WC, Rothman R. Availability of rapid human immunodeficiency virus testing in academic emergency departments. Acad Emerg Med. 2008;15(2):144-150.
41. Centers for Disease Control and Prevention. Number of persons tested for HIV - United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;53(47):1110-1113.
42. McCaig LF, Nawar EN. Advanced Data From Vital and Health Statistics: National Hospital Ambulatory Medical Care Survey: 2004 Emergency Department Summary, #372. http://www.cdc.gov/nchs/data/ad/ad372.pdf. Accessed July 28, 2008.
43. McQuillan GM, Kruszon-Moran D, Kottiri BJ, et al. Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002. J Acquir Immune Defic Syndr. 2006;41(5):651-656.
44. Centers for Disease Control and Prevention. Trends in HIV/AIDS diagnosis among men who have sex with men - 33 states, 2001-2006. MMWR Morb Mortal Wkly Rep. 2008;57(25):681-686.
45. Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med. 2008;168(11):1181-1191.
46. Lee LM, McKenna MT. Monitoring the incidence of HIV infection in the United States. Public Health Rep. 2007;122(suppl 1):72-79.
47. Bartlett JG, Mayer KH. Opportunities for improving the diagnosis of, prevention of, and access to treatment for HIV infection in the United States. Clin Infect Dis. 2007;45(suppl 4):S203-S205.